Skip to main content

Miller Andrew Craig's Form 4 filing

Karuna Therapeutics, Inc. (KRTX) · filed Dec 2, 2022

Accession no.
0001593968-22-001691
Filed
Dec 2, 2022
Trade date
Dec 1-2, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.42M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Miller Andrew CraigCIK 0001777760Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 2, 2022Common StockMOption exerciseAcquired+250$7.27+$1,817.525,750Direct
Dec 2, 2022Common StockMOption exerciseAcquired+500$2.92+$1,46026,250Direct
Dec 1, 2022Common StockSSaleDisposed−15,000$228.30−$3,424,50011,250Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 2, 2022Common StockMOption exerciseDisposed−250$0.00$011,578Direct
Dec 2, 2022Common StockMOption exerciseDisposed−500$0.00$054,917Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)